Stella Pharma Corp.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 0.00% vs -42.86% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -31.64% vs -35.05% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "61.60",
          "val2": "61.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-229.20",
          "val2": "-206.50",
          "chgp": "-10.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "1.50",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-268.80",
          "val2": "-204.20",
          "chgp": "-31.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,837.40%",
          "val2": "-3,468.90%",
          "chgp": "-36.85%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -66.35% vs 256.62% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -454.62% vs 81.56% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "323.40",
          "val2": "961.10",
          "chgp": "-66.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-720.40",
          "val2": "-55.50",
          "chgp": "-1,198.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.30",
          "val2": "4.10",
          "chgp": "78.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-780.90",
          "val2": "-140.80",
          "chgp": "-454.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,316.00%",
          "val2": "-93.90%",
          "chgp": "-222.21%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

61.60

61.60

Operating Profit (PBDIT) excl Other Income

-229.20

-206.50

-10.99%

Interest

3.00

1.50

100.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-268.80

-204.20

-31.64%

Operating Profit Margin (Excl OI)

-3,837.40%

-3,468.90%

-36.85%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 0.00% vs -42.86% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -31.64% vs -35.05% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

323.40

961.10

-66.35%

Operating Profit (PBDIT) excl Other Income

-720.40

-55.50

-1,198.02%

Interest

7.30

4.10

78.05%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-780.90

-140.80

-454.62%

Operating Profit Margin (Excl OI)

-2,316.00%

-93.90%

-222.21%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is -66.35% vs 256.62% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -454.62% vs 81.56% in Mar 2025

All Annual Results